Skip to main content


Page 1 of 4

  1. Hypoxia-mediated radioresistance is the main obstacle to the successful treatment of glioblastoma (GBM). Enhancing hypoxic radiosensitivity and alleviating tumor hypoxia are both effective means to improve the...

    Authors: Fangshi Zhao, Xiaoyi Wang, Wei Zhu, Dongju Zhao, Caihua Ye, Yanyan Guo and Yan Dou
    Citation: Cancer Nanotechnology 2023 14:8
  2. Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe.

    Authors: Mohamed M. Swidan, Basma M. Essa and Tamer M. Sakr
    Citation: Cancer Nanotechnology 2023 14:6
  3. Curcumin-loaded nanocomplexes (CNCs) previously demonstrated lower toxicity and extended release better than is the case for free curcumin. Here, we evaluated the efficacy of CNCs against opisthorchiasis-assoc...

    Authors: Chanakan Jantawong, Yaovalux Chamgramol, Kitti Intuyod, Aroonsri Priprem, Chawalit Pairojkul, Sirinapha Klungsaeng, Rungtiwa Dangtakot, Thatsanapong Pongking, Chutima Sitthirach, Porntip Pinlaor, Sakda Waraasawapati and Somchai Pinlaor
    Citation: Cancer Nanotechnology 2023 14:5
  4. To avoid the harmful side effects of cetuximab and improve its therapeutic efficacy, egg serum albumin (ESA) was used as a targeting drug carrier moiety for cancer therapy against Caco-2 colon cancer cells. Th...

    Authors: Elsayed I. Salim, Abeer M. Mosbah, F. A. Elhussiny, Nemany A. N. Hanafy and Y. Abdou
    Citation: Cancer Nanotechnology 2023 14:4
  5. Essential oils (EOs) are complex structures and possess several pharmacological effects. Nanomedicine offers a solution for their major limitations, including poor solubility, volatility, and non–controlled re...

    Authors: Khaled AbouAitah, Heba A. Hassan, Naglaa M. Ammar, Doha H. Abou Baker, Imane M. Higazy, Olfat G. Shaker, Ahmed A. A. Elsayed and Abeer M. E. Hassan
    Citation: Cancer Nanotechnology 2023 14:3
  6. Hepatoma is a serious public health concern. New attempts are urgently needed to solve this problem. Melittin, a host defense peptide derived from the venom of honeybees, has noteworthy hemolysis and non-speci...

    Authors: Xin Jin, Qing Yang, Guoli Wei, Jie Song and Zhenhai Zhang
    Citation: Cancer Nanotechnology 2023 14:2
  7. Chemo-radiotherapy is the combined chemotherapy and radiotherapy on tumor treatment to obtain the local radiosensitization and local cytotoxicity of the tumor and to control the microscopic metastatic disease.

    Authors: Shu-Jyuan Yang, Jui-An Pai, Cheng-Jung Yao, Chung-Huan Huang, Jenny Ling‑Yu Chen, Chung-Hao Wang, Ke-Cheng Chen and Ming-Jium Shieh
    Citation: Cancer Nanotechnology 2023 14:1
  8. Various types of cancer therapy strategies have been investigated and successfully applied so far. There are a few modern strategies for improving drug selectivity and biocompatibility, such as nanoparticle-ba...

    Authors: Seyed Mohammad Reza Seyedi, Ahmad Asoodeh and Majid Darroudi
    Citation: Cancer Nanotechnology 2022 13:44
  9. Gadolinium-based contrast agents (GdCAs) have been the most frequently used T1-weighted magnetic resonance imaging (MRI) contrast agents for decades. However, they have serious disadvantages such as low longitudi...

    Authors: Abolfazl Sarikhani, Zahra Alamzadeh, Jaber Beik, Rasoul Irajirad, Mehri Mirrahimi, Vahid Pirhajati Mahabadi, S. Kamran Kamrava, Habib Ghaznavi and Samideh Khoei
    Citation: Cancer Nanotechnology 2022 13:43
  10. Developing multifunctional composites has received widespread attention for cancer treatment. Herein, a metal–phenolic network (MPN)-based composite loading with chemotherapy agents (TAFP) exhibits high anti-t...

    Authors: Xiaoxiao Chen, Lulu Wang, Sijia Liu, Xuezhen Luo, Kai Wang and Qizhi He
    Citation: Cancer Nanotechnology 2022 13:41
  11. Small-molecule tyrosine kinase inhibitors (TKIs) represent a potentially powerful approach to the treatment of osteosarcoma (OS). However, dose-limiting toxicity, therapeutic efficacy, and targeting specificit...

    Authors: Federica Giordano, Stefania Lenna, Gherardo Baudo, Riccardo Rampado, Matteo Massaro, Enrica De Rosa, April Ewing, Lyazat Kurenbekova, Marco Agostini, Jason T. Yustein and Francesca Taraballi
    Citation: Cancer Nanotechnology 2022 13:40
  12. Quantum nanodots especially carbon nanoparticles (CNPs) have been widely studied in biomedicine in imaging, and drug delivery, but anti-cancer mechanisms remain elusive.

    Authors: Haiyan Fan, Qinglei Sun, Kanat Dukenbayev, Enrico Benassi, Limara Manarbek, Ayan A. Nurkesh, Medina Khamijan, Chenglin Mu, Guoliang Li, Madina Razbekova, Zhenbang Chen, Amr Amin and Yingqiu Xie
    Citation: Cancer Nanotechnology 2022 13:39
  13. The development of nanoparticle agents for MRI-guided radiotherapy is growing at an increasing pace, with clinical trials now underway and many pre-clinical evaluation studies ongoing. Gadolinium and iron-oxid...

    Authors: Leon Smith, Hilary L. Byrne, David Waddington and Zdenka Kuncic
    Citation: Cancer Nanotechnology 2022 13:38

    The Correction to this article has been published in Cancer Nanotechnology 2022 13:42

  14. Despite different nanomaterials were developed so far against cancer, their potential drawbacks are still scarcely considered. The off-target delivery of a therapeutic compound, as well as the non-specific upt...

    Authors: Sugata Barui, Nicolò Maria Percivalle, Marzia Conte, Bianca Dumontel, Luisa Racca, Marco Carofiglio and Valentina Cauda
    Citation: Cancer Nanotechnology 2022 13:37
  15. There are significant challenges in developing drug carriers for therapeutic perspective. We have investigated a novel nanocarrier system, based on combining functionalized magnetic nanocomposite with Metal–Or...

    Authors: Mahdieh Darroudi, Seyedeh Elnaz Nazari, Fereshteh Asgharzadeh, Nima Khalili-Tanha, Ghazaleh Khalili-Tanha, Toktam Dehghani, Maryam Karimzadeh, Mina Maftooh, Gordon A. Fern, Amir Avan, Majid Rezayi and Majid Khazaei
    Citation: Cancer Nanotechnology 2022 13:36
  16. Inorganic nanocomposites especially Au nanostructures have exhibited outstanding physicochemical properties in biomedical fields. For further clinical applications on theranostics, especially drug delivery, nu...

    Authors: Hua Yao, Xupeng Mu, Zhenhong Wei, Xiuying Li, Liya Wu, Yongri Jin, Xuwen Li, Jing Li and Jinlan Jiang
    Citation: Cancer Nanotechnology 2022 13:35
  17. Pancreatic ductal adenocarcinoma (PDAC) remains one of the most fatal malignancies. Several chemotherapies employing fluorouracil (5-FU) and gemcitabine were attempted, but the survival rate was extremely low....

    Authors: Dong Gun Lee, Mindong Lee, Eun Byeol Go and Namhyun Chung
    Citation: Cancer Nanotechnology 2022 13:34
  18. Cancer stem cell (CSC) and ferroptosis play critical roles in cancer development, but the underlying mechanisms remain unclear. Cervical cancer induces a great mortality and an increased incidence globally. Zi...

    Authors: Jie-Yun Lei, Shuang-Xue Li, Feng Li, Hui Li and Yuan-Sheng Lei
    Citation: Cancer Nanotechnology 2022 13:33
  19. For people with advanced hepatocellular carcinoma (HCC), systemic chemotherapy remains the only choice of palliative treatment. However, chemotherapy efficacy is not effective due to its short blood circulatio...

    Authors: Jiaji Ling, Yongmei Jiang, Shaoying Yan, Hao Dang, Huan Yue, Kanglin Liu, Linghan Kuang, Xingxin Liu and Hua Tang
    Citation: Cancer Nanotechnology 2022 13:32
  20. Nano-biotechnology-based clinical applications to cure health-related issues have gained huge attention among the scientific community and hold great promise to limit cancer metastasis. In this study, green-de...

    Authors: Muhammad Javed Iqbal, Umer Rashid, Zeeshan Javed, Zara Hamid, Komal Imran, Ayesha Kabeer, Shahid Raza, Zainab M. Almarhoon, Željko Reiner, Iulia-Cristina Bagiu, Radu Vasile Bagiu, Ioan Sarac, Javad Sharifi-Rad, Alibek Ydyrys, Sevgi Durna Daştan, Monica Butnariu…
    Citation: Cancer Nanotechnology 2022 13:31
  21. Nanoparticle-based photothermal therapy (PTT) is capable of inducing immunogenic cell death (ICD) and eradicating local tumor via hyperthermia. However, it can hardly prevent tumor recurrence and metastasis ow...

    Authors: Yunchao Wu, Jinqian Zhu, Qianzhe Li, Mengyu Yang, Xin Sun, Guojun Zheng, Fengyi Du and Miaomiao Zhang
    Citation: Cancer Nanotechnology 2022 13:30
  22. In this paper, we step forward in optimizing the efficiency of niosomal systems for carrying curcumin and miR-34a as single-/co-delivery to treat breast cancer. Curcumin, via regulation of p53 protein, affects...

    Authors: Najmeh Alsadat Abtahi, Seyed Morteza Naghib, Fatemeh Haghiralsadat and Mohammadmahdi Akbari Edgahi
    Citation: Cancer Nanotechnology 2022 13:28
  23. Compound K (CK) is the minor ginsenoside present in fermented Panax ginseng extract. Despite the pharmacological efficacy of CK, its industrial use has been restricted due to its low water solubility and poor per...

    Authors: Aditi Mitra Puja, Xingyue Xu, Rongbo Wang, Hoon Kim and Yeon-Ju Kim
    Citation: Cancer Nanotechnology 2022 13:27
  24. The ongoing loss of human life owing to various forms of cancer necessitates the development of a more effective/honorable therapeutic approach. Moreover, finding a novel green-synthesized anti-cancer therapy ...

    Authors: Nouf M. Alyami, Hanadi M. Alyami and Rafa Almeer
    Citation: Cancer Nanotechnology 2022 13:26
  25. To enhance the performance of radiotherapy, emerging nanoparticles that can professionally enhance X-ray irradiation to destruct cancer cells are extremely necessary. Here, we examined the potential of PEG-coa...

    Authors: Mahshid Mohammadian, Soraya Emamgholizadeh Minaei and Amin Shiralizadeh Dezfuli
    Citation: Cancer Nanotechnology 2022 13:25
  26. Photothermal therapy (PTT) has become an attractive approach for cancer treatment due to its merits of minimal invasiveness, location selectivity, and suitability for various cancer types. In PTT, photosensiti...

    Authors: Xinyu Qu, Yixing Chen, Zhuyun Cai, Xinyu Zhao, Hua Zeng, Xiaohao Liu, Shuo Tan, Bingqiang Lu, Rui Gao and Feng Chen
    Citation: Cancer Nanotechnology 2022 13:24
  27. Most ovarian cancers are diagnosed at advanced stages characterized by abdominal dissemination and frequently exhibit chemoresistance. Pyruvate dehydrogenase kinase 2 (PDK2) regulates the switch between glycol...

    Authors: Meng Zhang, Ming Du, Xingling Qi, Yumeng Wang, Guiling Li, Congjian Xu and Xiaoyan Zhang
    Citation: Cancer Nanotechnology 2022 13:23
  28. Multi-drug delivery system based on polymer carrier is emerging for alleviating dose-limiting toxicities of first-line cytotoxic anticancer drugs, such as doxorubicin (DOX) for breast cancer chemotherapy. By c...

    Authors: Zhiyong Li, Jiali Liu, Zheng Sun, Yanli Li, Bin Yu, Feng Zhao, Hongbo Wang and Hui Xu
    Citation: Cancer Nanotechnology 2022 13:21
  29. This research was performed to synthesize nanophytosome-loaded high phenolic fraction (HPF) from Juniperus polycarpos fruit extract and investigate its antiproliferation effects against breast cancer in mice mode...

    Authors: Soheila Moeini, Ehsan Karimi and Ehsan Oskoueian
    Citation: Cancer Nanotechnology 2022 13:20
  30. Targeted delivery of chemotherapeutic drugs to tumour cells is a major challenge for cancer chemotherapy. Recent studies show that tumour cell-derived microparticles can be used as vectors to package chemother...

    Authors: Zhou Jiang, Kai Li, Yongzhong Luo, Bin Chen, Fanfan Meng, Huifang Yi, Lemeng Zhang, Hua Yang, Wenwei Zhou, Tianli Cheng, Huihuang Yi, Qing Yi, Xiaoping Wen, Sheng Hu, Hongyan Liu and Jianhua Chen
    Citation: Cancer Nanotechnology 2022 13:19
  31. Despite the increasing interest in combination therapy for the treatment of cancer, controlled delivery of different therapeutics with high body-clearance efficacy and cancer cell specificity remained a great ...

    Authors: Bei Liu, Xiaoning Liu, Xiangyu Zhang, Xi Wu, Chuanbo Li, Zhaogang Sun and Hongqian Chu
    Citation: Cancer Nanotechnology 2022 13:18
  32. A targeted co-administration system of docetaxel (DTX) and curcumin (CUR) using a PEG-modified RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carrier (P/R-NLC) was constructed to exert synergi...

    Authors: Chang Hyun Kim, Byoung Deok Kim, Tae Hwa Lee, Hyeon Kyun Kim, Min Jeong Lyu, Young In Yoon, Yoon Tae Goo, Myung Joo Kang, Sangkil Lee and Young Wook Choi
    Citation: Cancer Nanotechnology 2022 13:17
  33. Tumor-promoting factors (TPF) and metabolic reprogramming are hallmarks of cancer cell growth. This study is designed to combine the newly synthesized two nanocomposites DDM (HA-FA-2DG@DCA@MgO) and AF (HA-FA-A...

    Authors: Noura M. Thabet, Mohamed K. Abdel-Rafei, Gharieb S. El-Sayyad, Mohamed Abd Elkodous, Adel Shaaban, Yi-Chun Du, Laila Ahmed Rashed and Mostafa A. Askar
    Citation: Cancer Nanotechnology 2022 13:16
  34. Nanoparticles play a crucial role in nanodiagnostics, radiation therapy of cancer, and they are now widely used to effectively deliver drugs to specific sites, targeting whole organs and down to single cells, ...

    Authors: Dmitri V. Alexandrov, Nickolay Korabel, Frederick Currell and Sergei Fedotov
    Citation: Cancer Nanotechnology 2022 13:15
  35. Hepatocellular carcinoma (HCC) is one of the most dangerous cancers in all the world. This study focused on prevention and therapy of hepatocellular carcinoma (HCC) using Moringa oleifera extract combined with vi...

    Authors: Eman M. M. Ebrahem, Galal H. Sayed, Gehan N. A. Gad, Kurls E. Anwer and Adli A. Selim
    Citation: Cancer Nanotechnology 2022 13:14
  36. Helicobacter pylori (H. pylori) eradication plays a crucial role in gastric cancer prevention, but the antimicrobial resistance of H. pylori is obstructing this elimination process. In this study, we developed na...

    Authors: Fansen Meng, Hongjin Tao, Yan Mi, Tianyu Yang, Xuanping Wang, Yuyo Go, Yunjuan Lin and Gangshi Wang
    Citation: Cancer Nanotechnology 2022 13:13
  37. In the current study, folic acid-conjugated PEG-PCL-PEG triblock copolymer were synthesized and loaded with 5-fluorouracil and magnetite nanoparticles (5-FU-SPION-PEG-PCL-PEG-FA) for targeted delivery of drug ...

    Authors: Parvin Sadat Mirzaghavami, Samideh Khoei, Sepideh Khoee and Sakine Shirvalilou
    Citation: Cancer Nanotechnology 2022 13:12
  38. Inherent limitations of single cancer therapy are overcome by multi-therapy modality, which integrates characteristics of each therapeutic modality and material chemistry. The multi-modal method has the potent...

    Authors: Kanglin Liu, Shaoying Yan, Zhengshu Liu, Dan Wang, Qing Yang, Xinyun Jiang, Liuxian Chen and Hua Tang
    Citation: Cancer Nanotechnology 2022 13:11
  39. Immune checkpoint blockade (ICB)-based cancer immunotherapy presents promising efficacy in cancer treatment. However, only a small portion of patients show responsiveness to the treatment, which is partially c...

    Authors: Yuxia Ma, Yi Liu, Ying Zhi, Haibin Wang, Mei Yang, Jieting Niu, Li Zhao and Pengsheng Wang
    Citation: Cancer Nanotechnology 2022 13:10
  40. Recently, biosensors have become popular analytical tools for small analytes due to their high sensitivity and wide analytical range. In the present work, development of a novel biosensing method based on tung...

    Authors: Ramin Pourakbari, Mehdi Yousefi, Balal Khalilzadeh, Mahsa Haddad Irani-nezhad, Alireza Khataee, Leili Aghebati-Maleki, Alireza Soleimanian, Amin Kamrani, Forough Chakari-Khiavi, Rozita Abolhasan, Morteza Motallebnezhad, Farhad Jadidi-Niaragh, Bahman Yousefi, Hossein Samadi Kafil, Mohammad Hojjat-Farsangi and Mohammad-Reza Rashidi
    Citation: Cancer Nanotechnology 2022 13:7
  41. There is growing potential for nanocarrier-based drug delivery in cancer. However, an incomplete understanding of nano–bio interactions and the challenges regarding processing and fabrication in scale-up engin...

    Authors: Mujibur Khan, Md. Mahmudul Hasan, Anne Barnett, Raziye Piranlioglu, Mohammad Rashid, Ahmet Alptekin and Ali Arbab
    Citation: Cancer Nanotechnology 2022 13:6
  42. RNA interference holds tremendous potential in the treatment of malignant tumors. However, efficient and biocompatible delivery methods are needed for systemic delivery of small interfering RNA (siRNA). In thi...

    Authors: Shanrong Shu, Xiaoping Liu, Ming Xu, Yaduan Lin and Ruiman Li
    Citation: Cancer Nanotechnology 2022 13:5
  43. Chemotherapy is widely used to treat hepatocellular carcinoma (HCC). Although sorafenib (SO) is the only chemotherapy drug approved by FDA for treatment of HCC, it is associated with several disadvantages incl...

    Authors: Huan Yue, Luxia Gou, Zhenrong Tang, Yuyang Liu, Shengchun Liu and Hua Tang
    Citation: Cancer Nanotechnology 2022 13:4
  44. Zinc oxide nanoparticles (ZONs) are a type of nanomaterial that has presented anti-cancer properties in breast cancer (BC). However, the function of ABCC9 in BC and its correlation with ZONs are still elusive.

    Authors: Yang Li, Cui Jiang, Xiaoxue Zhang, Zhixuan Liao, Long Chen, Shuang Li, Shunxiong Tang, Zhe Fan and Qiang Zhang
    Citation: Cancer Nanotechnology 2022 13:3

Journal Metrics